Clinical Trial Update: HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for HR-MRI–directed tirofiban therapy in late-window acute ischemic stroke, with status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• tirofiban (tirofiban)

Snippet

Sponsor: Weifang Medical University | Conditions: Stroke, Acute, Stroke, Ischemic | Phase 3 | Status: NOT_YET_RECRUITING